Malaysia is an emerging economy with a vision to build its biotechnology industry. The QB3-Malaysia Program represents a collaborative effort between the Malaysian Government and the California Institute for Quantitative Biosciences (QB3) to develop the biotech ecosystem in Malaysia, particularly in the drug discovery to address unmet medical needs and the development of natural product based therapeutics.